In addition, targeting other neutrophil proteins like Azurocidin (AZU1) and cathepsin G (CTSG) that are elevated in nasopharyngeal swaps of COVID-19 patients, as well as the inhibition of NET formation, have been suggested to alleviate SARS-CoV-2 symptoms [97,101,123]. Here, AZU1 is linked to COVID-19.